NCT06504329

Brief Summary

This study investigates the treatment of gingival recession (specifically Miller Class I and II defects) using a minimally invasive surgical approach known as the modified coronally advanced tunnel (MCAT) technique. Participants are allocated into three groups: one receiving subepithelial connective tissue grafts (SCTG), another treated with enamel matrix derivatives (EMD), and a third group receiving a combination of SCTG and EMD. The primary objective is to evaluate the clinical effectiveness of each treatment modality in terms of root coverage, esthetic outcomes, and postoperative patient comfort. The study also aims to determine whether the combined use of SCTG and EMD provides superior clinical results compared to their individual application. Both short-term and long-term treatment outcomes are assessed to identify the most effective approach for managing gingival recession.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
52

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jan 2024

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 24, 2024

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

July 1, 2024

Completed
15 days until next milestone

First Posted

Study publicly available on registry

July 16, 2024

Completed
8 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 24, 2024

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

January 24, 2025

Completed
Last Updated

June 24, 2025

Status Verified

June 1, 2025

Enrollment Period

6 months

First QC Date

July 1, 2024

Last Update Submit

June 18, 2025

Conditions

Keywords

Gingival recessionmodified coronally advanced tunnelenamel matrix derivativesubepithelial connective tissue graft

Outcome Measures

Primary Outcomes (1)

  • Percentage of Root Surface Coverage (%RC)

    The percentage of root surface coverage will be calculated based on changes in the exposed root surface area before and after treatment. The exposed area is estimated by multiplying the height and width of the gingival recession. The difference between the baseline and 6-month postoperative values will be used to determine the percentage of coverage. Results will be expressed as a percentage (%). This approach reflects the clinical effectiveness of the intervention and is based on the method described by Al-Hamdan et al. (2003).

    6 months postoperatively

Secondary Outcomes (9)

  • Gingival Index (GI)

    Baseline, 1, 3, and 6 months postoperatively

  • Plaque Index (PI)

    Baseline, 1, 3, and 6 months postoperatively.

  • Gingival Recession Height (GRH)

    Baseline, 1, 3, and 6 months postoperatively

  • Gingival Recession Width (GRW)

    Baseline, 1, 3, and 6 months postoperatively.

  • Clinical Attachment Level (CAL)

    Baseline and 6 months postoperatively.

  • +4 more secondary outcomes

Study Arms (3)

Modified Coronally Advanced Tunnel (MCAT) + Subepithelial Connective Tissue Graft (SCTG)

EXPERIMENTAL

Participants in this arm receive the modified coronally advanced tunnel (MCAT) technique in combination with a subepithelial connective tissue graft (SCTG).

Procedure: Modified Coronally Advanced Tunnel (MCAT) + Subepithelial Connective Tissue Graft (SCTG)

Modified Coronally Advanced Tunnel (MCAT) + Enamel Matrix Derivative (EMD)

EXPERIMENTAL

Participants in this arm receive the modified coronally advanced tunnel (MCAT) technique along with application of Emdogain (0.15 ml gel form), used as an enamel matrix derivative (EMD) to promote periodontal tissue regeneration.

Procedure: Modified Coronally Advanced Tunnel (MCAT) + Enamel Matrix Derivative (EMD)

MCAT + Subepithelial Connective Tissue Graft (SCTG) + Enamel Matrix Derivative (EMD)

EXPERIMENTAL

Participants in this arm receive the modified coronally advanced tunnel (MCAT) technique in combination with a subepithelial connective tissue graft and application of an enamel matrix derivative (EMD; Emdogain, 0.15 ml gel form) to support periodontal tissue regeneration.

Procedure: Modified Coronally Advanced Tunnel (MCAT) + Subepithelial Connective Tissue Graft (SCTG)Procedure: Modified Coronally Advanced Tunnel (MCAT) + Enamel Matrix Derivative (EMD)

Interventions

The modified coronally advanced tunnel (MCAT) technique is performed to prepare a recipient site. A subepithelial connective tissue graft (SCTG), harvested from the palate, is inserted into the tunnel using guiding sutures and stabilized. The flap is advanced coronally to completely cover the graft and achieve primary closure.

MCAT + Subepithelial Connective Tissue Graft (SCTG) + Enamel Matrix Derivative (EMD)Modified Coronally Advanced Tunnel (MCAT) + Subepithelial Connective Tissue Graft (SCTG)

This intervention involves the application of enamel matrix derivative (EMD; Emdogain, 0.15 ml gel form) in conjunction with the modified coronally advanced tunnel (MCAT) technique. Following tunnel preparation, EMD is applied to the exposed root surface to enhance periodontal tissue regeneration.

MCAT + Subepithelial Connective Tissue Graft (SCTG) + Enamel Matrix Derivative (EMD)Modified Coronally Advanced Tunnel (MCAT) + Enamel Matrix Derivative (EMD)

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Adults aged between 18 and 60 years
  • Systemically and periodontally healthy individuals
  • Non-smokers
  • Presence of a clearly detectable cementoenamel junction (CEJ)
  • No prior surgical intervention at the selected sites
  • No periodontal pockets deeper than 3 mm
  • No signs of occlusal trauma

You may not qualify if:

  • Pregnancy or lactation
  • Use of antibiotics in the past 6 months
  • Presence of any systemic condition that may contraindicate periodontal surgery, including:
  • Diabetes mellitus
  • Impaired glucose tolerance
  • Endocrine disorders
  • Cardiovascular diseases

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Necmettin Erbakan University, Faculty of Dentistry

Konya, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Gingival Recession

Interventions

Acyl-Carrier Protein S-Malonyltransferase

Condition Hierarchy (Ancestors)

Gingival DiseasesPeriodontal DiseasesMouth DiseasesStomatognathic DiseasesPeriodontal Atrophy

Intervention Hierarchy (Ancestors)

AcyltransferasesTransferasesEnzymesEnzymes and Coenzymes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
CARE PROVIDER
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
DDS, Research Assistant in the Department of Periodontology

Study Record Dates

First Submitted

July 1, 2024

First Posted

July 16, 2024

Study Start

January 24, 2024

Primary Completion

July 24, 2024

Study Completion

January 24, 2025

Last Updated

June 24, 2025

Record last verified: 2025-06

Data Sharing

IPD Sharing
Will not share

Locations